BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/20/2014 6:38:00 PM | Browse: 751 | Download: 584
Publication Name World Journal of Gastroenterology
Manuscript ID 7427
Country United Kingdom
Received
2013-11-18 08:33
Peer-Review Started
2013-11-18 13:01
To Make the First Decision
2013-12-16 17:21
Return for Revision
2013-12-17 11:37
Revised
Second Decision
2014-04-23 09:14
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-04-23 10:13
Articles in Press
2014-05-23 09:53
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-08-07 14:51
Publish the Manuscript Online
2014-08-20 18:38
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Review
Article Title Noninvasive biomarkers in non-alcoholic fatty liver disease: Current status and a glimpse of the future
Manuscript Source Invited Manuscript
All Author List Emer Fitzpatrick and Anil Dhawan
Funding Agency and Grant Number
Corresponding Author Anil Dhawan, Professor, Paediatric Liver, GI and Nutrition Centre, King”s College London School of Medicine at King’s College Hospital, London SE5 9PJ, United Kingdom. anil.dhawan@kcl.ac.uk
Key Words Noninvasive biomarkers; Nonalcoholic fatty liver disease; Fibrosis
Core Tip The search for non invasive biomarkers is a major focus of interest in the field of nonalcoholic fatty liver disease (NAFLD). Though the diagnosis of NAFLD is still a histological one, the dramatic rise in prevalence and the spectrum of severity mean that liver biopsy has become impractical for all. Both serum biomarkers of inflammation and fibrosis and assessment of fibrosis using techniques such as transient elastography may have a role to play. Newer techniques (the “omics”) may not only lead to novel biomarkers but also allow better understanding of the pathophysiology of the condition.
Publish Date 2014-08-20 18:38
Citation Fitzpatrick E, Dhawan A. Noninvasive biomarkers in non-alcoholic fatty liver disease: Current status and a glimpse of the future. World J Gastroenterol 2014; 20(31): 10851-10863
URL http://www.wjgnet.com/1007-9327/full/v20/i31/10851.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i31.10851
Full Article (PDF) WJG-20-10851.pdf
Full Article (Word) WJG-20-10851.doc
Manuscript File 7427-Review.docx
Answering Reviewers 7427-Answering reviewers.pdf
Copyright License Agreement 7427-Copyright assignment.pdf
Peer-review Report 7427-Peer reviews.pdf
Scientific Editor Work List 7427-Scientific editor work list.doc